EUVIMEDEUVIMED entdecken
Open Access

Metabolic sensor AMPK licenses intestinal CD103 + DCs to induce T reg responses

Thiago A Patente iD, Julian van Duijvenvoorde iD, Graham A Heieis iD, Eline C Brombacher iD, Leonard R Pelgrom iD, Joost Lambooij iD, Anna Zawistowska-Deniziak iD, Martina Erbì iD, Frank Otto, Arifa Ozir-Fazalalikhan iD, Sara Barnhoorn, José J Fernández iD und 7 weitere

Science Advances · 2026

DOI: 10.1126/sciadv.aeb4813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Thiago A Patente und 18 weiteren Autor:innen. Beteiligte Einrichtung: Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands. Hauptthemen laut MEDLINE: Dendritic Cells, Integrin alpha Chains, T-Lymphocytes, Regulatory, AMP-Activated Protein Kinases. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Leiden University, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, São Paulo Foundation Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intestinal dendritic cells (DCs) play a central role in maintaining gut tolerance through priming of peripheral regulatory T cells (pT reg cells). DC tolerogenicity has been linked to catabolic metabolism, but the role of AMP-activated kinase (AMPK), a key regulator of catabolic metabolism, in regulating intestinal tolerance remains unclear. We found high AMPK activation in intestinal DCs, and loss of AMPKα1 in CD11c-expressing cells (CD11c ΔAMPKα1 ) led to reduced frequencies of intestinal RALDH + CD103 + cDC2s. This was associated with reduced pT reg cell induction and consequently increased type 2 immunity in models of intestinal helminth infection. Correspondingly, CD103 + cDC2s from helminth-infected CD11c ΔAMPKα1 mice failed to prime T reg cells ex vivo. Similarly, T reg cell induction by AMPK-deficient human retinoic acid (RA)–induced tolerogenic CD103 + DCs was compromised. Mechanistically, AMPK underpinned RA-driven tolerogenicity by promoting RALDH activity and TGF-β secretion in a FoxO3-dependent manner, independent from metabolic reprogramming. Our findings identify AMPK as a key regulator of intestinal DC-mediated tolerance and as a therapeutic target to counter intestinal inflammatory disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsIntegrin alpha ChainsT-Lymphocytes, RegulatoryAMP-Activated Protein KinasesAntigens, CDIntestinesAnimalsMiceTretinoinImmune ToleranceHumansIntestinal MucosaMetabolic ReprogrammingRetinal Dehydrogenase

Substanzen

Integrin alpha Chainsalpha E integrinsAMP-Activated Protein KinasesAntigens, CDTretinoinRetinal Dehydrogenase

Autor:innen und Institutionen

  • Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
  • Pathogen Immunobiology Group, Institute of Experimental Zoology, Faculty of Biology, University of Warsaw, 02-96 Warsaw, Poland.
  • Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands.
  • Laboratory of Tumor Immunology, Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • School of Infection and Immunity, University of Glasgow, 120 University Place, G12 8TA Glasgow, UK.

ORCID-Profile: Thiago A Patente, Julian van Duijvenvoorde, Graham A Heieis, Eline C Brombacher, Leonard R Pelgrom, Joost Lambooij, Anna Zawistowska-Deniziak, Martina Erbì, Arifa Ozir-Fazalalikhan, José J Fernández, Alwin J van der Ham, Lukas J A C Hawinkels, Bruno A Guigas, José A M Barbuto, Bart Everts

Förderung

  • Leiden University
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • São Paulo Foundation Research

Zitieren

APA

Patente, T. A., van Duijvenvoorde, J., Heieis, G. A., Brombacher, E. C., Pelgrom, L. R., Lambooij, J., Zawistowska-Deniziak, A., Erbì, M., Otto, F., Ozir-Fazalalikhan, A., Barnhoorn, S., Fernández, J. J., van der Reijden, J., van der Ham, A. J., Hawinkels, L. J. A. C., Guigas, B. A., Barbuto, J. A. M., Maizels, R. M., & Everts, B. (2026). Metabolic sensor AMPK licenses intestinal CD103 + DCs to induce T reg responses. Science Advances. https://doi.org/10.1126/sciadv.aeb4813

Vancouver

Patente TA, van Duijvenvoorde J, Heieis GA, Brombacher EC, Pelgrom LR, Lambooij J, et al. Metabolic sensor AMPK licenses intestinal CD103 + DCs to induce T reg responses. Science Advances. 2026. doi:10.1126/sciadv.aeb4813

BibTeX
@article{Patente2026,
  author = {Patente, Thiago A and van Duijvenvoorde, Julian and Heieis, Graham A and Brombacher, Eline C and Pelgrom, Leonard R and Lambooij, Joost and Zawistowska-Deniziak, Anna and Erbì, Martina and Otto, Frank and Ozir-Fazalalikhan, Arifa and Barnhoorn, Sara and Fernández, José J and van der Reijden, Johan and van der Ham, Alwin J and Hawinkels, Lukas J A C and Guigas, Bruno A and Barbuto, José A M and Maizels, Rick M and Everts, Bart},
  title = {Metabolic sensor AMPK licenses intestinal CD103 + DCs to induce T reg responses},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aeb4813}
}
Kostenlos starten →